Yuan Yuan, M.D., PH.D.

47% fewer Medicare Part D claims than the average medical oncology physician in 2024

376 Medicare Part D claims for 95 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. Brand-name drugs were 26% of claims.

Most prescribed

1. Letrozole69 claims
2. Prochlorperazine Maleate30 claims
3. Ondansetron Hcl28 claims
4. Kisqali18 claims
5. Truqap16 claims
6. Pregabalin15 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 85.7 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $25,787.16

25 payments; by number, the most common kind was food and beverage; the largest payer was Gilead Sciences, Inc. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

2 hospitals and group practices

1. Cedars-Sinai Medical CenterWest Hollywood, CA · Acute Care Hospitals5 of 5 stars
2. Cedars-Sinai Medical Care FoundationPasadena, CA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through); hospitals matched to CMS Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.